Instruments and methods for reducing and stabilizing bone fractures

Information

  • Patent Grant
  • 8562634
  • Patent Number
    8,562,634
  • Date Filed
    Friday, February 24, 2012
    12 years ago
  • Date Issued
    Tuesday, October 22, 2013
    10 years ago
Abstract
Instruments and methods for reducing and stabilizing bone fractures are presented, which include providing a cavity in bone, such as a vertebra, wherein the cavity is proximate to an endplate of the bone, such as a vertebra endplate, and wherein the cavity extends radially from a passage into the cavity. The methods further include providing a device, such as an inflatable device, into the cavity and manipulating the device for expansion. The cavity may be expanded thereby reducing and/or stabilizing the fracture. The fracture may be further reduced and/or stabilized by adding a material into the cavity.
Description
BACKGROUND

The invention described generally relates to instruments and methods for application with skeletal disorders, and, in particular relates to instruments and methods for the reduction and stabilization of skeletal fractures.


Fracture reduction and/or stabilization are generally practiced to substantially restore or repair skeletal structures to their pre-fractured state. In practice, materials, such as in-situ curable materials (e.g., bone cements) and/or implants are often used to help stabilize fractured bone. In one clinical procedure known as vertebroplasty, bone cement is injected into a fractured vertebral body to stabilize bone fragments. This and other procedures may also additionally use one or a number of devices for reduction and stabilization of a fracture. For vertebroplasty, a device is used to assist in the formation of a cavity in the vertebra prior to injection of the in-situ curable material. Another device used with some procedures is a bone tamp used to reduce the fracture.


SUMMARY

The present invention solves many problems associated with current methods and devices for reduction, stabilization, restoration, and repair of skeletal fractures.


Generally, and in one form described herein are methods of reducing and/or stabilizing a fracture in bone. The method includes cutting a portion of the bone having a fracture to create a cavity. The cavity may be substantially axisymmetric and may be cut using any suitable device, such as a tissue cavitation device. The cavity is then expanded to reduce the fracture. A suitable expanding device includes a medical balloon as an example. The expanding device is typically positioned proximate to cortical bone. The fracture may be further reduced by filling the cavity with a material. The material may fully or partially fill the cavity. Examples of suitable materials include implants and in-situ materials that are curable or hardenable. Such materials may be permanent, resorbable, penetrating and combinations thereof. The material filling the cavity offers stabilization to the fracture. Any bone fragments near the fracture may also be stabilized. When suitable, the cutting of a portion of the bone having a fracture is preceded by the formation of at least one passage to the fracture site. Depending on the type of bone having the fracture, the passage(s) may be intracortical, extracortical, intrapedicular, extrapedicular, and combinations thereof.


Additionally, described herein is a method for treating bone comprising the steps of: forming a passage in a vertebra; forming a cavity in the vertebra, wherein the cavity at least extends radially from the passage, wherein the cavity has a first size and a first portion of the cavity is proximate to a vertebral endplate; providing an inflatable device configured for expansion; introducing the inflatable device configured for expansion into the cavity; and expanding the inflatable device configured for expansion to provide an expansion force sufficient to enlarge the cavity to a second size. The expansion force may be provided proximate to the vertebral endplate, comprising a first endplate and a second endplate. The expansion force may be provided to reduce a vertebral compression fracture. The first endplate may be a superior endplate and the second endplate may be an inferior endplate. Forming the cavity comprises a method of cutting bone, the method of cutting bone selected from the group consisting of shearing, cutting, scraping, and combinations thereof. The inflatable device may be a balloon. The inflatable device may be non-compliant. The inflatable device may be semi-compliant. The inflatable device may be configured to manipulate cortical bone to reduce a fracture. The method may further comprise filling the cavity with a material after expanding the inflatable device, the material selected from the group consisting of implantable material, in-situ curable material, in-situ hardenable material, permanent material, resorbable material, penetrating material, and combinations thereof. The passage in the vertebra may comprise forming an entry hole from which the cavity is formed. Forming the cavity may further comprise cutting bone. The cavity may be substantially axisymmetric. The cavity may be substantially non-axisymmetric. In one form, the second size of the cavity has an increased volume as compared with a volume associated with the first size of the cavity. Forming the passage in the vertebra may precede forming the cavity. Forming the passage in the vertebra may occur substantially concomitantly with forming the cavity.


Still further, described herein is a method for treating bone comprising the steps of: forming a passage in a vertebra along a linear axis; providing a tissue cavitation device; forming a cavity in the vertebra with the tissue cavitation device, wherein the cavity has first volume that extends from the passage proximate to a first vertebral endplate; providing an inflatable device configured for expansion in the cavity; and expanding the inflatable device configured for expansion within the cavity to expand the cavity to a second volume, wherein the second volume is greater than the first volume. The cavity is proximate to a second vertebral endplate. The cavity is proximate to but separated from the first vertebral endplate by a layer of cancellous bone. The cavity has a boundary and a portion of the boundary consists of cortical bone. The cavity has a boundary and a portion of the boundary consists of cancellous bone. The inflatable device configured for expansion is a balloon. In one form, expanding the inflatable device manipulates cortical bone to reduce a fracture. The method may further comprise filling the cavity after expanding with a material, wherein the material is a filling material selected from the group consisting of implant material, in-situ curable material, in-situ hardenable material, permanent material, resorbable material, penetrating material, and combinations thereof. In one form, forming the passage in the vertebra comprises forming an entry hole about which the cavity is formed. Forming the cavity in the vertebra may comprise disrupting bone. The cavity may be substantially axisymmetric. The cavity may be substantially non-axisymmetric. The cavity may be formed with rotational actuation of the tissue cavitation device. Forming the passage in the vertebra may precede forming the cavity. Forming the passage in the vertebra may occur substantially concomitantly with the step of forming the cavity.


Also described herein is a method of treating bone comprising the steps of: forming a passage in a vertebra; providing a tissue cavitation device, inserting the tissue cavitation device into the passage; forming a cavity with the tissue cavitation device along a central portion of the vertebra, wherein the cavity extends proximate to a vertebral body endplate; providing an inflatable device configured for expansion with a working fluid; inserting the inflatable device into the cavity that is the central portion of the vertebra; and expanding the inflatable device to expand the cavity. The cavity may be proximate a first region of the vertebral body endplate which includes cortical bone. The cavity may be proximate a second region of the vertebral body endplate which includes cortical bone, wherein the first region is a superior endplate and the second region is an inferior endplate. The cavity may be proximate a first region of the vertebral body endplate and separated from the first region by a layer of cancellous bone. In one form, the cavity has a boundary, a portion of which is cortical bone. The cavity may also have a boundary, a portion of which is cancellous bone. Forming the cavity may comprise a method of separating bone, the method of separating bone selected from the group consisting of shearing, cutting, scraping, and combinations thereof. The inflatable device may be a balloon. The inflatable device may be substantially non-compliant. The inflatable device may be semi-compliant. The inflatable device may be used to manipulate cortical bone to reduce a fracture. The method may further comprise filling the cavity with a material, wherein the material is a filling material selected from the group consisting of implant material, in-situ curable material, in-situ hardenable material, permanent material, resorbable material, penetrating material, and combinations thereof. The cavity may be substantially axisymmetric. The cavity may be substantially non-axisymmetric. In one form, a working end of the tissue cavitation device is transformable between a first shape for entry into the passage and a second shape for forming the cavity. In one or more embodiments, the tissue cavitation device comprises: a shaft having a diameter and a longitudinal axis; and flexible cutting element associated with the shaft, wherein the flexible cutting element is configured to assume a first shape for insertion and configured to assume a second shape suitable for forming the cavity that has a diameter greater than a diameter of the shaft when the shaft is rotated about the longitudinal axis of the shaft. The cavity is formed with rotational actuation of the tissue cavitation device. Wherein forming the passage in the vertebra may precedes forming the cavity. Wherein forming the passage in the vertebra may occur substantially concomitantly with forming the cavity. In some forms, expanding the inflatable device provides a distraction force.


A method for treating bone is also described that comprises: forming a passage in a vertebra along a linear axis; providing a tissue cavitation device; forming a cavity in the vertebra with the tissue cavitation device by separating bone, wherein the cavity is formed with rotational actuation of the tissue cavitation device, wherein the cavity extends from the passage; providing an inflatable device configured for expansion; and expanding the inflatable device configured for expansion within the cavity to enlarge the cavity.


Those skilled in the art will further appreciate the above-noted features and advantages of the invention together with other important aspects thereof upon reading the detailed description that follows in conjunction with the drawings.





BRIEF DESCRIPTION OF SEVERAL VIEWS OF THE DRAWINGS

For a more complete understanding of the features and advantages of the present invention, reference is now made to the detailed description of the invention along with the accompanying figures in which corresponding numerals in the different figures refer to corresponding parts and in which:



FIG. 1 is a superior view of a human bone;



FIG. 2A is another superior view of a human bone showing the bone a working channel;



FIG. 2B is a cross-sectional view of the bone in FIG. 2A or FIG. 1 showing a fracture;



FIG. 3 is a schematic of a device useful with the present invention showing (A) a side view, (B) a perspective view, and (C) a detailed perspective view of a portion of the device;



FIG. 4A is a superior view of the bone of FIG. 1 with a fracture site and after performing a step of the present invention;



FIG. 4B is a cross-sectional view of the bone of FIG. 4A showing the step of FIG. 4A and a cavity within the bone;



FIG. 5A is a superior view of the bone of FIG. 4A when performing another step of the present invention;



FIG. 5B is a cross-sectional view of the bone of FIG. 5A showing the step of FIG. 5A and an expanding device in the cavity of the bone;



FIG. 6A is a superior view of the bone of FIG. 5A when performing yet another step of the present invention;



FIG. 6B is a cross-sectional view of the bone of FIG. 6A showing the step of FIG. 6A and a restored bone;



FIG. 7A is a superior view of the bone of FIG. 5A when performing still another step of the present invention; and



FIG. 7B is a cross-sectional view of the bone of FIG. 7A showing the bone with an in-situ material in the cavity.





DETAILED DESCRIPTION

Although making and using various embodiments of the present invention are discussed in detail below, it should be appreciated that the present invention provides many inventive concepts that may be embodied in a wide variety of contexts. The specific aspects and embodiments discussed herein are merely illustrative of ways to make and use the invention, and do not limit the scope of the invention


In the description which follows like parts may be marked throughout the specification and drawing with the same reference numerals, respectively. The drawing figures are not necessarily to scale and certain features may be shown exaggerated in scale or in somewhat generalized or schematic form in the interest of clarity and conciseness.


Instruments and methods will be disclosed for reducing and stabilizing bone fractures. The method may be useful for fractured bone, including vertebral bone. Typically, vertebral bone fractures in compression. This type of fracture is most common in the thoracic and/or lumbar regions of the spine and may coincide with regions of osteoporotic bone.


Common medical nomenclature may be used when describing aspects of the present invention. As used herein, superior is nearer the head in relation to a specific reference point, inferior is nearer the feet in relation to a specific reference point, anterior is forward in relation to a specific reference point and posterior is rearward in relation to a specific reference point. The midsagittal plane is an imaginary plane dividing the body into a right side and left side. A frontal plane is any imaginary vertical plane orthogonal to the midsagittal plane.


Referring not to FIG. 1, the figure shows anatomical structures of a human bone. In this example, the bone is vertebra 1 in a superior view. Vertebra 1 is comprised of body 2 and posterior elements 3. Posterior elements 3 include pedicle 4. An edge view of midsagittal reference plane 18 is shown in FIG. 1 as line X-X. Body 2 is generally comprised of two types of bone: cortical bone 12 and cancellous bone 14. In contrast to cortical bone, cancellous bone has a substantial degree of porosity. In addition there are transition regions of varying porosity between cancellous and cortical bone. For the present invention, the bone does not necessarily require all the above-identified elements. For example, some bone do not comprise pedicle 4; other bone may be more symmetrical in shape when shown in superior view. All bone, however, will include a body with some degree of cancellous bone and some degree of cortical bone.


Vertebral 1 of FIG. 1 is shown in a superior view in FIG. 2A. FIG. 2B shows relevant cortical bone 12 structures including superior endplate 8, inferior endplate 8′, and side wall 10. As a possible site of fracture, fracture 16 is shown to include side wall 10 and cancellous bone 14. Fractures may also occur in locations such as superior endplate 8 and inferior endplate 8′, as examples.


Continuing to refer to FIG. 2A and FIG. 2B, passage 70 is formed within body 2 using any of a number of methods and surgical instruments known to one of ordinary skill in the art. Examples of possible surgical instruments used to create passage 70 include a bone biopsy needle, guide pin, stylet, stylus, drill-bit instrument, and obturator. Referring again to FIG. 2A, working channel 20 is typically used to pass instruments into and out of body 2. While body 2 will typically have a working channel, the formation of passage 70 may not be essential. In some instances, a drill-bit instrument is used within working channel 20 to create passage 70, wherein the diameter of passage 70 is similar to the inner diameter of working channel 20. Other appropriate instruments may also be used with the working channel. Working channel 20 typically remains in position for additional steps of the present invention. As shown in FIG. 2A, access to body 2 is thru pedicle 4 (intrapedicular); however access may also include one or a number of posterior elements 3 or may be outside pedicle 4 (extrapedicular). The surgical approach typically depends on the site of the fracture, the patient, and/or surgeon preferences.


The term “tissue cavitation device” as used herein will refer to a device useful with the present invention. This device is capable of separating a portion of bone having a fracture and providing a cavity in the portion of the bone including or near the site of the fracture. By use of such a device, the device may separate the bone by cutting, shearing or scraping the bone, as examples. The separation creates a cavity that is typically substantially larger in diameter than the access passage, as shown in FIG. 2A as passage 70. A suitable device and use of such a device is described in U.S. Pat. No. 6,746,451 to Middleton et. al, which is hereby incorporated by reference. The Middleton device is comprised of a rotatable shaft interconnected to a flexible cutting element. The flexible cutting element has a first shape suitable for minimally invasive passage into tissue, and the flexible cutting element has a means to move toward a second shape suitable for forming a cavity in the tissue, such as bone. Several embodiments of the Middleton device may also be adapted to a powered and/or a manual surgical drill, as needed.


Referring now to FIG. 3A, FIG. 3B, and FIG. 3C, examples of a suitable device are shown. Device 30 comprises a flexible cutting element 32, a shaft 34, a serration 36, and a T-handle 38. T-handle 38 allows the user (e.g., surgeon) to rotate device 30 during use or in the formation of a cavity.


Referring now to FIG. 4A and FIG. 4B, vertebra 1 is shown with cavity 72 provided after use of a device, such as device 30 shown in FIG. 3. Here, cavity 72 was created by using a device, such as device 30, within passage 70 to cut a portion of the bone, the bone being cancellous bone 14 and/or cortical bone 12. Although passage 70 is useful to position device 30, it is contemplated that a cavity 72 can be made without requiring passage 70. Cavity 72, as shown in FIG. 4A and FIG. 4B, is generally spherical, although other shapes are also contemplated, such as cylindrical and elliptical shapes, as examples. In general, it is desirable to extend the boundary of cavity 72 so that it at least partially includes, or is in proximity of, superior endplate 8 and inferior endplate 8′. Hence, cavity 72 is typically in proximity to cortical bone 12. Accordingly, cavity 72 may be bound, in part, by cortical bone 12. Cavity 72 is initially formed by device 30; in which device 30 cuts, shears, and/or scrapes a portion of bone near the fracture. Cavity 72 is not initially formed by compacting the bone using an expanding device.


Often, it is desirable to have the height and width of cavity 72 be of similar or equal dimensions. Therefore, an axisymmetric shape of cavity 72 is useful, although non-axisymmetric shapes are also contemplated. For example, device 30, shown in FIG. 3, may be designed, through the use of available materials and geometry, to effectively cut cancellous bone but ineffectively cut cortical bone which may lead to a non-axisymmetric bone cavity, despite complete rotation of shaft 34 during use of device 30. Alternatively, both cancellous and cortical bone may be cut by device 30. Thus, the boundaries of the cavity may be cortical and/or cancellous bone. Various elements of the present invention, to include position and size of the bone cavity, will become apparent to one of ordinary skill in the art.


A further step to reduce the fracture includes expansion of the cavity with an expanding device. The expanding device is one that expands the shape of the cavity in at least one dimension. The device, itself may be involved in the expansion. Alternatively, one or more materials may be used with the device for such expansion. Example of expanding devices are a medical balloon or SKy Bone Expander (Disc Orthopaedic Technologies Inc., New Jersey, USA). Other suitable expandable means may also be used. Referring now to FIG. 5A and FIG. 5B, expanding device 40 is positioned within cavity 72. For FIGS. 5A and 5B, expanding device 40 is a medical balloon which is inflated with working substance 46, such as a fluid or saline. Readily available surgical inflation devices, including a syringe and syringe-like devices, are suitable for pressurizing the expanding device. Not every expanding device, however, will require pressurization. Each expanding device will have components and functions known to those skilled in the art. For example, expanding device 40 as shown in FIG. 5A and FIG. 5B, typically comprises an expandable portion 41, inner cannula 42, and outer cannula 44. The expandable portion 41 may be constructed of a number of materials, such as a non-compliant or semi-compliant material (e.g., poly(ethylene terephthalate) or Nylon). For any expanding device, the expanding portion may be resorbable, nonresorbable, porous or nonporous.


In general, because cortical bone is stiffer and stronger as compared with cancellous bone, expanding device 40 may be positioned initially at or in proximity to cortical bone 12. The position of expanding device 40 is typically based on the size, shape, and location of cavity 72. For example, with expanding device 40 as a medical balloon, the top and bottom surface of expandable portion 41 may be initially positioned at or in proximity of cortical bone 12 upon initial pressurization of expandable portion 41. Therefore expandable portion 41 may provide relatively direct distraction forces against superior endplate 8 and inferior endplate 8′ upon pressurization of expandable portion 41. The width of expandable portion 41 relates to the vertical distraction forces expandable portion 41 provides for a given pressure. Relative to passage 70, cavity 72 is typically larger, allowing pressurization of a relatively large expandable portion 41. Thus, for a given pressure, a larger expanding expandable portion 41 would generally provide greater distraction forces. Or, for a required distraction force, a larger expanding portion 41 generally requires lower pressure. Typically, a larger expanding device provides greater surface area for distraction and provides broader, more uniform distraction, while avoiding local pressure concentrations. Referring to FIG. 5B, H1 represents the height of body 2 prior to reduction of the fracture. Inflation of expandable portion 41 is intended to reduce the fracture in the form of an increased body height of the bone in at least one dimension.


Referring now to FIG. 6A and FIG. 6B, body 2 is shown following inflation of expanding device 40 of FIG. 5 and removal of expanding device 40. An expanding device may include an implantable portion subsequently left in the patient to become permanent or later resorbed. In suitable embodiments, an expandable portion of expanding device 40 may remain in cavity 72′ and be filled with a material further described below. The material and/or the expandable portion may remain permanently in cavity 72′ or be later resorbed.


Referring specifically to FIG. 6B, a new vertebral body height, H2, is established in the cavity, reflecting partial or significant restoration toward the pre-fractured height of body 2. In addition, cavity 72, as initially shown in FIG. 4, is now enlarged or otherwise modified, as represented in FIG. 6A and FIG. 6B by cavity 72′. Cavity 72′ may, thus, be associated with a reduction of the fracture. This may include, for example as described above, a change in the spatial relationship between endplate 8 and endplate 8′.


The fracture may be further reduced and/or stabilized by any of a number of means, including introduction of a material. Some examples of suitable materials include an implant, a support, an in situ material that is hardenable or curable, and other equivalents. An example of a material used for further reduction is shown in FIG. 7A and FIG. 7B. Here, cavity 72′ is filled with in-situ material 50 to provide stability and strength to body 2. The in-situ material 50 may fully or partially fill the volume of cavity 72′, including between any bone fragments and any related fractures, especially fracture fissures interconnected directly to cavity 72′. In-situ curable material 50 may also penetrate the pores of cancellous bone 14. The in-situ material may be a permanent material or may be resorbable. Alternatively, the Suitable in-situ materials that be hardened or curable include polymethylmethacrylate-based bone cements and bone substitute materials, such as calcium sulfate compounds, calcium phosphate compounds, demineralized allografts, hydroxyapetites, carbonated apetites (e.g., Synthes' Norian Bone Void Filler), collagen mixtures, mineral and cytokine mixtures, terpolymer resins, difunctional resins (e.g., Orthovita's CORTOSS®), and combinations thereof, as examples. Any passage to cavity 72 and 72′, if present, such as working channel 20 or passage 70, is either filled or allowed to heal. Any components used for the introduction of material 50 (or its equivalents) are similarly removed.


The instruments and methods presented in this disclosure are used as examples of the present invention. Those skilled in the art will be able to develop modifications and variants that do not depart from the spirit and scope of the present invention. Variations include using a porous expanding device. Alternately, an expanding device may be filled with a material (e.g., implant or in-situ material that is curable or hardenable) and subsequently left in the patient to become permanent or later resorbed. It is also understood that the expanding device may be an implant or include an implant and, thus, all or part of the device may remain in cavity 72′. Such implants may be metallic or nonmetallic, coated or noncoated.


Alternate surgical approaches are also within the scope of the present invention. For example the instruments and methods may be used on the right side and left side of a body of a bone, such as in a bipedicular approach for vertebral bone. The present invention is applicable to the reduction and stabilization of any bone or fracture site, including fractured vertebra. Accordingly, the present invention offers restoration and repair of a fractured bone comprising cortical and/or cancellous bone.


Additional objects, advantages and novel features of the invention as set forth in the description, will be apparent to one skilled in the art after reading the foregoing detailed description or may be learned by practice of the invention. The objects and advantages of the invention may be realized and attained by means of the instruments and combinations particularly pointed out here.

Claims
  • 1. A method for treating bone comprising the steps of: forming a passage in a vertebra;providing a tissue cavitation device,inserting the tissue cavitation device into the passage in the vertebra;forming a cavity with the tissue cavitation device along a central portion of the vertebra, wherein the cavity extends proximate to an endplate of a vertebral body, wherein the cavity is proximate a first region and a second region of the vertebral body, wherein the first region is a superior endplate and the second region is an inferior endplate;providing an inflatable device configured for expansion with a working fluid;inserting the inflatable device into the cavity that is the central portion of the vertebra; andexpanding the inflatable device to expand the cavity.
  • 2. The method of claim 1, wherein the cavity is proximate a first region of the vertebral body endplate and separated from the first region by a layer of cancellous bone.
  • 3. The method of claim 1, wherein the cavity has a boundary, a portion of which is cortical bone.
  • 4. The method of claim 1, wherein the cavity has a boundary, a portion of which is cancellous bone.
  • 5. The method of claim 1, wherein forming the cavity comprises a method of separating bone, the method of separating bone selected from the group consisting of shearing, cutting, scraping, and combinations thereof.
  • 6. The method of claim 1, wherein the inflatable device is a balloon.
  • 7. The method of claim 1, wherein the inflatable device is substantially non-compliant.
  • 8. The method of claim 1, wherein the inflatable device is semi-compliant.
  • 9. The method of claim 1, wherein expanding the inflatable device manipulates cortical bone to reduce a fracture.
  • 10. The method of claim 1, further comprising filling the cavity with a material, wherein the material is a filling material selected from the group consisting of implant material, in-situ curable material, in-situ hardenable material, permanent material, resorbable material, penetrating material, and combinations thereof.
  • 11. The method of claim 1, wherein the cavity is substantially axisymmetric.
  • 12. The method of claim 1, wherein the cavity is substantially non-axisymmetric.
  • 13. The method of claim 1, wherein a working end of the tissue cavitation device is transformable between a first shape for entry into the passage and a second shape for forming the cavity.
  • 14. The method of claim 1, wherein the tissue cavitation device comprises: a shaft having a diameter and a longitudinal axis; anda flexible cutting element associated with the shaft, wherein the flexible cutting element is configured to assume a first shape for insertion and configured to assume a second shape suitable for forming the cavity that has a diameter greater than a diameter of the shaft when the shaft is rotated about the longitudinal axis of the shaft.
  • 15. The method of claim 1, wherein the cavity is formed with rotational actuation of the tissue cavitation device.
  • 16. The method of claim 1, wherein forming the passage in the vertebra precedes forming the cavity.
  • 17. The method of claim 1, wherein forming the passage in the vertebra occurs substantially concomitantly with forming the cavity.
  • 18. The method of claim 1, wherein expanding the inflatable device provides a distraction force.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 11/140,413 filed May 27, 2005, which claims the benefit of U.S. Provisional Patent Application No. 60/575,635 filed May 28, 2004. The entirety of both patent applications are hereby incorporated by reference to the fullest extent allowable.

US Referenced Citations (377)
Number Name Date Kind
1685380 Shultz Sep 1928 A
3030951 Mandarino Apr 1962 A
3112743 Cochran et al. Dec 1963 A
3320957 Sokolik May 1967 A
4065817 Branemark et al. Jan 1978 A
4313434 Segal Feb 1982 A
4369772 Miller Jan 1983 A
4403606 Woo et al. Sep 1983 A
4403607 Woo et al. Sep 1983 A
4493317 Klaue et al. Jan 1985 A
4494535 Haig Jan 1985 A
4503848 Caspar et al. Mar 1985 A
4513744 Klaue et al. Apr 1985 A
4653489 Tronzo Mar 1987 A
4743260 Burton May 1988 A
4751922 DiPietropolo Jun 1988 A
4773406 Spector et al. Sep 1988 A
4794918 Wolter et al. Jan 1989 A
4969888 Scholten et al. Nov 1990 A
5002544 Klaue et al. Mar 1991 A
5014124 Fujisawa May 1991 A
5019078 Perren et al. May 1991 A
5030201 Palestrant Jul 1991 A
5053036 Perren et al. Oct 1991 A
5062845 Kuslich et al. Nov 1991 A
5085660 Lin Feb 1992 A
5102413 Poddar Apr 1992 A
5108404 Scholten et al. Apr 1992 A
5116336 Frigg May 1992 A
5147361 Ojima et al. Sep 1992 A
5151103 Tepic et al. Sep 1992 A
5211651 Reger et al. May 1993 A
5275601 Gogolewski et al. Jan 1994 A
5303718 Krajicek Apr 1994 A
5344421 Crook Sep 1994 A
5360432 Shturman Nov 1994 A
5364399 Lowery et al. Nov 1994 A
5376100 Lefebvre et al. Dec 1994 A
5403136 Mathys et al. Apr 1995 A
5403317 Bonutti Apr 1995 A
5423850 Berger Jun 1995 A
5431671 Nallakrishnan Jul 1995 A
5445639 Kuslich et al. Aug 1995 A
5480400 Berger Jan 1996 A
5490859 Mische et al. Feb 1996 A
5514137 Coutts May 1996 A
5527311 Procter et al. Jun 1996 A
5540707 Ressemann et al. Jul 1996 A
5549612 Yapp et al. Aug 1996 A
5549679 Kuslich Aug 1996 A
5556429 Felt Sep 1996 A
5562672 Huebner et al. Oct 1996 A
5571189 Kuslich Nov 1996 A
5591170 Spievack et al. Jan 1997 A
5601553 Trebing et al. Feb 1997 A
5607426 Ralph et al. Mar 1997 A
5613967 Engelhardt et al. Mar 1997 A
5616144 Yapp et al. Apr 1997 A
5658310 Berger Aug 1997 A
5665110 Chervitz et al. Sep 1997 A
5674296 Bryan et al. Oct 1997 A
5681310 Yuan et al. Oct 1997 A
5681311 Foley et al. Oct 1997 A
5693011 Onik Dec 1997 A
5695513 Johnson et al. Dec 1997 A
5709686 Talos et al. Jan 1998 A
5720749 Rupp Feb 1998 A
5733287 Tepic et al. Mar 1998 A
5735853 Olerud et al. Apr 1998 A
5766176 Duncan Jun 1998 A
5772662 Chapman et al. Jun 1998 A
5800433 Benzel et al. Sep 1998 A
5807396 Raveh et al. Sep 1998 A
5827289 Reiley et al. Oct 1998 A
5843103 Wulfman Dec 1998 A
5871486 Huebner et al. Feb 1999 A
5888220 Felt et al. Mar 1999 A
5891145 Morrison et al. Apr 1999 A
5904683 Pohndorf et al. May 1999 A
5925056 Thomas et al. Jul 1999 A
5928239 Mirza Jul 1999 A
5935131 Bonutti Aug 1999 A
5964762 Biedermann et al. Oct 1999 A
5972015 Scribner et al. Oct 1999 A
5990194 Dunn et al. Nov 1999 A
6017345 Richelsoph Jan 2000 A
6019776 Preissman et al. Feb 2000 A
6022350 Ganem et al. Feb 2000 A
6030389 Wagner et al. Feb 2000 A
6033411 Preissman Mar 2000 A
6048343 Mathis et al. Apr 2000 A
6048346 Reiley et al. Apr 2000 A
6066154 Reiley et al. May 2000 A
6071284 Fox Jun 2000 A
6083672 Roefs et al. Jul 2000 A
6096054 Wyzgala et al. Aug 2000 A
6127597 Beyar et al. Oct 2000 A
6139509 Yuan et al. Oct 2000 A
6140452 Felt et al. Oct 2000 A
6171312 Beaty Jan 2001 B1
6210376 Grayson Apr 2001 B1
6214012 Karpman et al. Apr 2001 B1
6221029 Mathis et al. Apr 2001 B1
6224604 Suddaby May 2001 B1
6231615 Preissman May 2001 B1
6235043 Reiley et al. May 2001 B1
6238391 Olsen et al. May 2001 B1
6241734 Scribner et al. Jun 2001 B1
6248110 Reiley et al. Jun 2001 B1
6248131 Felt et al. Jun 2001 B1
6264659 Ross et al. Jul 2001 B1
6273916 Murphy Aug 2001 B1
6280456 Scribner et al. Aug 2001 B1
6283971 Temeles Sep 2001 B1
6296639 Truckai et al. Oct 2001 B1
6309420 Preissman Oct 2001 B1
6325806 Fox Dec 2001 B1
6348055 Preissman Feb 2002 B1
6358251 Mirza Mar 2002 B1
6375659 Erbe et al. Apr 2002 B1
6383188 Kuslich et al. May 2002 B2
6383190 Preissman May 2002 B1
6395007 Bhatnagar et al. May 2002 B1
6423083 Reiley et al. Jul 2002 B2
6425887 McGuckin et al. Jul 2002 B1
6425923 Stalcup et al. Jul 2002 B1
6440138 Reiley et al. Aug 2002 B1
6447514 Stalcup et al. Sep 2002 B1
6450973 Murphy Sep 2002 B1
6488667 Murphy Dec 2002 B1
6494535 Galbreath Dec 2002 B2
6558386 Cragg May 2003 B1
6558390 Cragg May 2003 B2
6558396 Inoue May 2003 B1
6565572 Chappius May 2003 B2
6575979 Cragg Jun 2003 B1
6582439 Sproul Jun 2003 B1
6582446 Marchosky Jun 2003 B1
6592559 Pakter et al. Jul 2003 B1
6595998 Johnson et al. Jul 2003 B2
6599520 Scarborough et al. Jul 2003 B2
6607544 Boucher et al. Aug 2003 B1
6613018 Bagga et al. Sep 2003 B2
6613054 Scribner et al. Sep 2003 B2
6613089 Estes et al. Sep 2003 B1
6620162 Kuslich et al. Sep 2003 B2
6626903 McGuckin, Jr. et al. Sep 2003 B2
6632235 Weikel et al. Oct 2003 B2
6641587 Scribner et al. Nov 2003 B2
6645213 Sand et al. Nov 2003 B2
6652568 Becker et al. Nov 2003 B1
6663647 Reiley et al. Dec 2003 B2
6676663 Higueras et al. Jan 2004 B2
6676664 Al-Assir Jan 2004 B1
6676665 Foley et al. Jan 2004 B2
6679886 Weikel et al. Jan 2004 B2
6685718 Wyzgala et al. Feb 2004 B1
6689132 Biscup Feb 2004 B2
6699242 Heggeness Mar 2004 B2
6706069 Berger Mar 2004 B2
6716216 Boucher et al. Apr 2004 B1
6719773 Boucher et al. Apr 2004 B1
6726691 Osorio et al. Apr 2004 B2
6730095 Olson, Jr. et al. May 2004 B2
6740090 Cragg et al. May 2004 B1
6740093 Hochschuler et al. May 2004 B2
6746451 Middleton et al. Jun 2004 B2
6749595 Murphy Jun 2004 B1
6752791 Murphy et al. Jun 2004 B2
6752809 Gorek Jun 2004 B2
6758855 Fulton, III et al. Jul 2004 B2
6758863 Estes et al. Jul 2004 B2
6770079 Bhatnagar et al. Aug 2004 B2
6780191 Sproul Aug 2004 B2
6790210 Cragg et al. Sep 2004 B1
6805697 Helm et al. Oct 2004 B1
6814734 Chappuis et al. Nov 2004 B2
6832988 Sproul Dec 2004 B2
6843796 Harari et al. Jan 2005 B2
6852095 Ray Feb 2005 B1
6863672 Reiley et al. Mar 2005 B2
6863676 Lee et al. Mar 2005 B2
6869445 Johnson Mar 2005 B1
6887246 Bhatnagar et al. May 2005 B2
6899716 Cragg May 2005 B2
6902547 Aves et al. Jun 2005 B2
6916308 Dixon et al. Jul 2005 B2
6921403 Cragg et al. Jul 2005 B2
6923813 Phillips et al. Aug 2005 B2
6932843 Smith et al. Aug 2005 B2
6939351 Eckman Sep 2005 B2
6960215 Olson, Jr. et al. Nov 2005 B2
6960900 Fogarty et al. Nov 2005 B2
6979341 Scribner et al. Dec 2005 B2
6979352 Reynolds Dec 2005 B2
6981981 Reiley et al. Jan 2006 B2
6984063 Barker et al. Jan 2006 B2
7001342 Faciszewski Feb 2006 B2
7008433 Voellmicke et al. Mar 2006 B2
7014633 Cragg Mar 2006 B2
7044954 Reiley et al. May 2006 B2
7056321 Pagliuca et al. Jun 2006 B2
7077865 Bao et al. Jul 2006 B2
7087058 Cragg Aug 2006 B2
7114501 Johnson et al. Oct 2006 B2
7144397 Lambrecht et al. Dec 2006 B2
7153305 Johnson et al. Dec 2006 B2
7153307 Scribner et al. Dec 2006 B2
7156860 Wallsten Jan 2007 B2
7156861 Scribner et al. Jan 2007 B2
7160306 Matsuzaki et al. Jan 2007 B2
7226481 Kuslich Jun 2007 B2
7234468 Johnson et al. Jun 2007 B2
7238209 Matsuzaki et al. Jul 2007 B2
7241297 Shaolian et al. Jul 2007 B2
7241303 Reiss et al. Jul 2007 B2
7252671 Scribner et al. Aug 2007 B2
7252686 Carrison et al. Aug 2007 B2
7295868 Bascle et al. Nov 2007 B2
7295869 Bascle et al. Nov 2007 B2
7309338 Cragg Dec 2007 B2
7318826 Teitelbaum et al. Jan 2008 B2
7326203 Papineau et al. Feb 2008 B2
7329259 Cragg Feb 2008 B2
7346385 Bascle et al. Mar 2008 B2
7399739 Shimp Jul 2008 B2
7473256 Assell et al. Jan 2009 B2
7476226 Weikel et al. Jan 2009 B2
7488320 Middleton Feb 2009 B2
7488377 Schroeter Feb 2009 B2
7491236 Cragg et al. Feb 2009 B2
7500977 Assell et al. Mar 2009 B2
7510579 Preissman Mar 2009 B2
7530993 Assell et al. May 2009 B2
7534245 Chappuis May 2009 B2
7534256 Cragg May 2009 B2
7540875 Jessen Jun 2009 B2
7544196 Bagga et al. Jun 2009 B2
7547324 Cragg et al. Jun 2009 B2
7553659 Brodeur et al. Jun 2009 B2
7555343 Bleich Jun 2009 B2
7569056 Cragg et al. Aug 2009 B2
7572263 Preissman Aug 2009 B2
7588574 Assell et al. Sep 2009 B2
7608077 Cragg et al. Oct 2009 B2
7637872 Fox Dec 2009 B1
7662173 Cragg et al. Feb 2010 B2
7717958 Cragg et al. May 2010 B2
7740633 Assell et al. Jun 2010 B2
7753872 Cragg et al. Jul 2010 B2
20010010431 Sasaki et al. Aug 2001 A1
20010011174 Reiley et al. Aug 2001 A1
20010012968 Preissman Aug 2001 A1
20010021852 Chappius Sep 2001 A1
20010041896 Reiley et al. Nov 2001 A1
20010044626 Reiley et al. Nov 2001 A1
20010049527 Cragg Dec 2001 A1
20020016583 Cragg Feb 2002 A1
20020016593 Hearn et al. Feb 2002 A1
20020022856 Johnson et al. Feb 2002 A1
20020026195 Layne et al. Feb 2002 A1
20020026197 Foley et al. Feb 2002 A1
20020029047 Bascle et al. Mar 2002 A1
20020032444 Mische Mar 2002 A1
20020068974 Kuslich et al. Jun 2002 A1
20020116064 Middleton Aug 2002 A1
20020156482 Scribner et al. Oct 2002 A1
20020173796 Cragg Nov 2002 A1
20020183758 Middleton et al. Dec 2002 A1
20020188300 Arramon et al. Dec 2002 A1
20030009208 Snyder et al. Jan 2003 A1
20030032929 McGuckin Feb 2003 A1
20030032963 Reiss et al. Feb 2003 A1
20030073998 Pagliuca et al. Apr 2003 A1
20030074075 Thomas et al. Apr 2003 A1
20030105469 Karmon Jun 2003 A1
20030109883 Matsuzaki et al. Jun 2003 A1
20030130664 Boucher et al. Jul 2003 A1
20030135237 Cragg et al. Jul 2003 A1
20030158557 Cragg et al. Aug 2003 A1
20030171812 Grunberg et al. Sep 2003 A1
20030191474 Cragg et al. Oct 2003 A1
20030191489 Reiley et al. Oct 2003 A1
20030195518 Cragg Oct 2003 A1
20030195547 Scribner et al. Oct 2003 A1
20030195628 Bao et al. Oct 2003 A1
20030204189 Cragg Oct 2003 A1
20030220648 Osorio et al. Nov 2003 A1
20030229353 Cragg Dec 2003 A1
20030229372 Reiley et al. Dec 2003 A1
20030233096 Osorio et al. Dec 2003 A1
20040010260 Scribner et al. Jan 2004 A1
20040010263 Boucher et al. Jan 2004 A1
20040010314 Matsuzaki et al. Jan 2004 A1
20040019354 Johnson et al. Jan 2004 A1
20040024409 Sand et al. Feb 2004 A1
20040024410 Olson et al. Feb 2004 A1
20040024463 Thomas et al. Feb 2004 A1
20040029248 Brodeur et al. Feb 2004 A1
20040039406 Jessen Feb 2004 A1
20040049202 Berger Mar 2004 A1
20040049203 Scribner et al. Mar 2004 A1
20040059417 Smith et al. Mar 2004 A1
20040064144 Johnson et al. Apr 2004 A1
20040068242 McGuckin Apr 2004 A1
20040073139 Hirsch et al. Apr 2004 A1
20040073308 Kuslich et al. Apr 2004 A1
20040087956 Weikel et al. May 2004 A1
20040092933 Shaolian et al. May 2004 A1
20040097930 Justis et al. May 2004 A1
20040098015 Weikel et al. May 2004 A1
20040098017 Saab et al. May 2004 A1
20040102774 Trieu May 2004 A1
20040122438 Abrams Jun 2004 A1
20040153064 Foley et al. Aug 2004 A1
20040153114 Reiley et al. Aug 2004 A1
20040153115 Reiley et al. Aug 2004 A1
20040167532 Olson et al. Aug 2004 A1
20040167561 Boucher et al. Aug 2004 A1
20040167562 Osorio et al. Aug 2004 A1
20040210231 Boucher et al. Oct 2004 A1
20040210297 Lin et al. Oct 2004 A1
20040215197 Smith et al. Oct 2004 A1
20040215343 Hochschuler et al. Oct 2004 A1
20040215344 Hochschuler et al. Oct 2004 A1
20040220577 Cragg et al. Nov 2004 A1
20040220580 Johnson et al. Nov 2004 A1
20040225296 Reiss et al. Nov 2004 A1
20040267269 Middleton et al. Dec 2004 A1
20050015148 Jansen et al. Jan 2005 A1
20050038439 Eckman Feb 2005 A1
20050038514 Helm et al. Feb 2005 A1
20050038517 Carrison et al. Feb 2005 A1
20050043737 Reiley et al. Feb 2005 A1
20050055097 Grunberg et al. Mar 2005 A1
20050070908 Cragg Mar 2005 A1
20050090852 Layne et al. Apr 2005 A1
20050113838 Phillips et al. May 2005 A1
20050113919 Cragg et al. May 2005 A1
20050113928 Cragg et al. May 2005 A1
20050113929 Cragg et al. May 2005 A1
20050119662 Reiley et al. Jun 2005 A1
20050124989 Suddaby Jun 2005 A1
20050131267 Talmadge Jun 2005 A1
20050131268 Talmadge Jun 2005 A1
20050131269 Talmadge Jun 2005 A1
20050131529 Cragg Jun 2005 A1
20050137601 Assell et al. Jun 2005 A1
20050137602 Assell et al. Jun 2005 A1
20050137604 Assell et al. Jun 2005 A1
20050137605 Assell et al. Jun 2005 A1
20050137607 Assell et al. Jun 2005 A1
20050137612 Assell et al. Jun 2005 A1
20050149034 Assell et al. Jul 2005 A1
20050149049 Assell et al. Jul 2005 A1
20050149191 Cragg et al. Jul 2005 A1
20050165406 Assell et al. Jul 2005 A1
20050182413 Johnson et al. Aug 2005 A1
20050182417 Pagano Aug 2005 A1
20050187556 Stack et al. Aug 2005 A1
20050203527 Carrison et al. Sep 2005 A1
20050261695 Cragg et al. Nov 2005 A1
20060004369 Patel et al. Jan 2006 A1
20060116689 Albans et al. Jun 2006 A1
20060116690 Pagano Jun 2006 A1
20060142795 Nguyen et al. Jun 2006 A1
20060149268 Truckai et al. Jul 2006 A1
20060155289 Windhager et al. Jul 2006 A1
20060235451 Schomer et al. Oct 2006 A1
20070027464 Way et al. Feb 2007 A1
20070055259 Norton et al. Mar 2007 A1
20070123877 Goldin et al. May 2007 A1
20080114364 Goldin et al. May 2008 A1
20080294166 Goldin et al. Nov 2008 A1
20080294167 Schumacher et al. Nov 2008 A1
20090131952 Schumacher et al. May 2009 A1
20100241123 Middleton et al. Sep 2010 A1
Foreign Referenced Citations (8)
Number Date Country
3914164 Jan 1991 DE
0442137 Aug 1991 EP
0442137 Aug 1991 EP
0748615 Dec 1996 EP
WO-9007304 Jul 1990 WO
WO-9851226 Nov 1998 WO
WO-9851226 Nov 1998 WO
WO-2004049961 Jun 2004 WO
Non-Patent Literature Citations (19)
Entry
Communication pursuant to Article 94(3) EPC dated Jun. 1, 2010 for Application No. EP 08769546.6.
European Search Report dated Jun. 11, 2010 for Application No. EP 10002071.8.
International Search Report and Opinion for PCT/US2006/044340 dated Oct. 22, 2007.
International Search Report and Written Opinion for PCT/US2008/064312 dated Jun. 10, 2009.
International Search Report for PCT/US2006/044443 dated Mar. 21, 2007.
Office Action dated Jan. 11, 2008 for U.S. Appl. No. 10/818,452.
Office Action dated Jun. 11, 2007 for U.S. Appl. No. 10/818,452.
Office Action dated Jun. 3, 2003 for U.S. Appl. No. 09/872,042.
Office Action dated Aug. 19, 2010 for U.S. Appl. No. 10/818,452.
Office Action dated Aug. 28, 2002 for U.S. Appl. No. 09/872,042.
Office Action dated Sep. 2, 2010 for U.S. Appl. No. 11/600,313.
Office Action dated Oct. 20, 2008 for U.S. Appl. No. 10/818,452.
Office Action dated Nov. 16, 2009 for U.S. Appl. No. 11/600,313.
Office Action dated Nov. 29, 2006 for U.S. Appl. No. 10/818,452.
Office Action dated Dec. 7, 2009 for U.S. Appl. No. 10/818,452.
Office Action dated Apr. 13, 2006 for U.S. Appl. No. 10/818,452.
Office Action dated Aug. 20, 2009 for U.S. Appl. No. 11/600,313.
U.S. Appl. No. 60/336,557, Middleton, filed Nov. 1, 2001.
Phillips, Frank M., “Minimally Invasive Treatments of Osteoporotic Vertebral Compression Fractures,” Spine, vol. 28, No. 15S, 2003, pp. S45-S53.
Related Publications (1)
Number Date Country
20120158142 A1 Jun 2012 US
Provisional Applications (1)
Number Date Country
60575635 May 2004 US
Continuations (1)
Number Date Country
Parent 11140413 May 2005 US
Child 13405061 US